RINVOQ, A ONCE-DAILY PILL PILL for giant cell arteritis

Focus on GCA remission and reducing steroids

RINVOQ is the first and only once-daily, non-steroid pill approved for the treatment of GCA. In a clinical trial, RINVOQ has been proven to help MORE people with GCA achieve remission than those on steroids alone. Those in remission on RINVOQ were able to:

1st & Only Once-daily Non-steroid Pill Approved for GCA

RINVOQ is the first and only once-daily, non-steroid pill approved for the treatment of GCA. In a clinical trial, RINVOQ has been proven to help MORE people with GCA achieve remission than those on steroids alone. Those in remission on RINVOQ were able to:

Taper off steroids in 6 months

Rapidly reach remission at 3 months

Stay in remission even at 1 year

Remission is defined as an absence of signs or symptoms of GCA.

Talk to a rheumatologist about managing your GCA long term, and see if RINVOQ may be right for you. 

Select Important Safety Information

RINVOQ may cause serious side effects, including:

  • Serious Infections, Cancer and Immune System Problems, and Blood Clots.
  • Increased risk of death in people age 50+ with at least 1 heart disease risk factor.
  • Increased risk of major cardiovascular events, such as heart attack, stroke, or death in people age 50+ with at least 1 heart disease risk factor, especially in current or past smokers.
  • Serious allergic reactions. Do not take if allergic to RINVOQ or its ingredients.

Safety Considerations

RINVOQ may cause serious side effects, including:

  • Serious infections. RINVOQ can lower ability to fight infections. Serious infections, some fatal, occurred, including tuberculosis (TB) and infections caused by bacteria, fungi, or viruses.
  • Increased risk of death in people age 50+ with at least 1 heart disease risk factor.
  • Cancer and immune system problems. Increased risk of some cancers, including lymphoma and skin. Current or past smokers have higher risk for lymphoma and lung cancer.
  • Increased risk of major cardiovascular events such as heart attack, stroke, or death in people age 50+ with at least 1 heart disease risk factor, especially in current or past smokers.
  • Blood clots, some fatal, in veins of the legs or lungs and arteries. This occurred more often in people 50+ with at least 1 heart disease risk factor.
  • Serious allergic reactions. Do not take if allergic to RINVOQ or its ingredients.
  • Tears in the stomach or intestines; changes in certain laboratory test results.

Learn more about these and the full Important Safety Information below.

Explore your savings options

An Insurance Specialist can help identify potential savings options—regardless of your insurance coverage.

Get to know RINVOQ

Sign up for RINVOQ emails and prepare for your next GCA appointment with helpful resources delivered right to your inbox.

Building a long-term treatment plan

As someone who may see multiple specialists and healthcare professionals, you need a doctor who can coordinate your care and has experience treating people living with GCA.

Finding a rheumatologist is an important step in your treatment journey. Use our tool to find a specialist in your area.